Bresnihan B, Hughes G, Essigman W K
Curr Med Res Opin. 1978;5(7):556-61. doi: 10.1185/03007997809109001.
A double-blind trial was carried out in 37 patients with osteoarthrosis to compare the efficacy and tolerance of 250 mg diflunisal twice daily with that of 400 mg ibuprofen 3-times daily over an 8-week period. Rating scale assessments were made, at the end of a preceding 1-week, wash-out period on placebo and at regular fixed intervals, of weight-bearing pain, night pain, a specific functional activity, and of the duration of inactivity stiffness. Patients' and physician's overall evaluations of response, taking side-effects into account, were made on completion of the study. The data collected indicated that in 30 patients completing the trial both treatments produced similar overall results and, with the exception of weight-bearing pain which appeared to be improved more in the ibuprofen group, diflunisal provided equal therapeutic benefit with fewer side-effects.
对37例骨关节炎患者进行了一项双盲试验,以比较每日两次服用250毫克双氟尼酸与每日三次服用400毫克布洛芬在8周内的疗效和耐受性。在之前为期1周的安慰剂洗脱期结束时以及在固定的定期时间,对负重疼痛、夜间疼痛、一项特定功能活动以及静止性僵硬的持续时间进行了评分量表评估。在研究结束时,综合考虑副作用,由患者和医生对反应进行了总体评估。收集到的数据表明,在完成试验的30例患者中,两种治疗产生了相似的总体结果,除了负重疼痛在布洛芬组似乎改善得更多外,双氟尼酸提供了同等的治疗益处且副作用更少。